中枢神经系统提供向蛋白质降解剂
Prashant Agarwal1, Darren L Reid2, Mansoor Amiji3
1Drug Product Technologies, Process Development, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, United States of America; Department of Chemical Engineering, College of Engineering, Northeastern University, 360 Huntington Ave, Boston, MA 02115, United States of America.
概括
向蛋白质降解剂 (TPDs) 由于其物理化学性质和血脑屏障 (BBB) 而面临向中枢神经系统 (CNS) 传递的挑战. 创新策略,包括先进的配方和理解E3结合酶表达,对于中枢神经系统TPD疗法至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 药物运输 药物运输 药物运输
背景情况:
- 异生物功能小分子降解剂是一种向蛋白降解剂 (TPD),提供了一种新的治疗方法.
- 这些化合物往往表现出具有挑战性的物理化学特性,使药物输送复杂化.
- 血脑屏障 (BBB) 是治疗中枢神经系统 (CNS) 疾病的一个重要障碍.
研究的目的:
- 审查目前改善向CNS提供TPD的策略.
- 探索TPD的创新配方和交付方法.
- 突出了解大脑中E3酶表达对中枢神经系统TPD发育的重要性.
主要方法:
- 对中枢神经系统疾病现有的TPD输送策略的文献综述.
- 对配方方法的分析,包括基于脂质和聚合物的系统.
- 讨论E3酶在中枢神经系统药物输送中的作用.
主要成果:
- 基于脂质和聚合物的长期作用的输送系统显示了对封装脂友性TPDs的承诺.
- 交付系统的功能化可以提高整个BBB的有针对性的交付.
- 识别中枢神经系统特异性的E3酶可以显著提高TPD在大脑中的疗效.
结论:
- 克服BBB对于推进中枢神经系统疾病的TPD治疗方法至关重要.
- 将TPD与先进药物输送相结合的综合方法是必不可少的.
- 进一步研究中枢神经系统中的E3酶生物学将开辟新的治疗途径.
相关概念视频
Drug Delivery: Parenteral Route
480
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
480
Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
The Proteasome
827
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
827


